Activation of GPER Induces Differentiation and Inhibition of Coronary Artery Smooth Muscle Cell Proliferation

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Li, Fen ^a,c   Yu, Xuan ^a   Szynkarski, Claudia K ^a   Meng, Cong ^b   Zhou, Beiyan ^b   Barhoumi, Rola ^b   White, Richard E ^d   Heaps, Cristine L ^a   Stallone, John N ^a   Han, Guichun ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c HENAN NORMAL UNIVERSITY   (China)

^d PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CYCLIN B1; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1; G PROTEIN COUPLED RECEPTOR 30; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; PROTEIN P21; TRANSGELIN; 1-(4-(6-BROMOBENZO(1,3)DIOXOL-5-YL)-3A,4,5,9B-TETRAHYDRO-3H-CYCLOPENTA(C)QUINOLIN-8-YL)ETHANONE; CYCLOPENTANE DERIVATIVE; ESTROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; GPER PROTEIN, HUMAN; QUINOLINE DERIVATIVE;

ANIMAL CELL; ARTICLE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY; DOWN REGULATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MIGRATION INHIBITION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SWINE; UPREGULATION; VASCULAR SMOOTH MUSCLE; AGONISTS; ANIMAL; CELL CULTURE; CORONARY BLOOD VESSEL; CYTOLOGY; DRUG EFFECTS; PHYSIOLOGY; PIG; SMOOTH MUSCLE CELL;

SUIDAE; SUS;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CORONARY VESSELS; CYCLOPENTANES; DOWN-REGULATION; HUMANS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; QUINOLINES; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; SWINE; UP-REGULATION;

EID: 84879228917     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064771     Document Type: Article

References (42)

1. Rzucidlo EM, Martin KA, Powell RJ, (2007) Regulation of vascular smooth muscle cell differentiation. J Vasc Surg 45 Suppl A: A25-32.
2. Owens GK, Kumar MS, Wamhoff BR, (2004) Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84: 767-801.
3. Farhat MY, Lavigne MC, Ramwell PW, (1996) The vascular protective effects of estrogen. Faseb J 10: 615-624.
4. Kawagoe J, Ohmichi M, Tsutsumi S, Ohta T, Takahashi K, et al. (2007) Mechanism of the divergent effects of estrogen on the cell proliferation of human umbilical endothelial versus aortic smooth muscle cells. Endocrinology 148: 6092-6099.
5. Dubey RK, Jackson EK, Gillespie DG, Zacharia LC, Imthurn B, et al. (2000) Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and mitogen-activated protein kinase activity. Arterioscler Thromb Vasc Biol 20: 964-972.
6. Sivritas D, Becher MU, Ebrahimian T, Arfa O, Rapp S, et al. (2011) Antiproliferative effect of estrogen in vascular smooth muscle cells is mediated by Kruppel-like factor-4 and manganese superoxide dismutase. Basic Res Cardiol 106: 563-575.
7. Liu HM, Zhao XF, Guo LN, Tan Z, Wang TH, (2007) Effects of caveolin-1 on the 17beta-estradiol-mediated inhibition of VSMC proliferation induced by vascular injury. Life Sci 80: 800-812.
8. Selzman CH, Gaynor JS, Turner AS, Whitehill TA, Horwitz LD, et al. (1998) Estrogen replacement inhibits intimal hyperplasia and the accumulation and effects of transforming growth factor beta1. J Surg Res 80: 380-385.
9. Foegh ML, Asotra S, Howell MH, Ramwell PW, (1994) Estradiol inhibition of arterial neointimal hyperplasia after balloon injury. J Vasc Surg 19: 722-726.
10. Takahashi K, Ohmichi M, Yoshida M, Hisamoto K, Mabuchi S, et al. (2003) Both estrogen and raloxifene cause G1 arrest of vascular smooth muscle cells. J Endocrinol 178: 319-329.
11. Iafrati MD, Karas RH, Aronovitz M, Kim S, Sullivan TR Jr, et al. (1997) Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nat Med 3: 545-548.
12. Karas RH, Hodgin JB, Kwoun M, Krege JH, Aronovitz M, et al. (1999) Estrogen inhibits the vascular injury response in estrogen receptor beta-deficient female mice. Proc Natl Acad Sci U S A 96: 15133-15136.
13. Karas RH, Schulten H, Pare G, Aronovitz MJ, Ohlsson C, et al. (2001) Effects of estrogen on the vascular injury response in estrogen receptor alpha, beta (double) knockout mice. Circ Res 89: 534-539.
14. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER, (2005) A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307: 1625-1630.
15. Thomas P, Pang Y, Filardo EJ, Dong J, (2005) Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146: 624-632.
16. Haas E, Bhattacharya I, Brailoiu E, Damjanovic M, Brailoiu GC, et al. (2009) Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. Circ Res 104: 288-291.
17. Lindsey SH, Cohen JA, Brosnihan KB, Gallagher PE, Chappell MC, (2009) Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2.Lewis rats. Endocrinology 150: 3753-3758.
18. Martensson UE, Salehi SA, Windahl S, Gomez MF, Sward K, et al. (2009) Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice. Endocrinology 150: 687-698.
19. Deschamps AM, Murphy E, (2009) Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats. Am J Physiol Heart Circ Physiol 297: H1806-1813.
20. Yu X, Ma H, Barman SA, Liu AT, Sellers M, et al. (2011) Activation of G protein-coupled estrogen receptor induces endothelium-independent relaxation of coronary artery smooth muscle. Am J Physiol Endocrinol Metab 301: E882-888.
21. Odenlund M, Holmqvist B, Baldetorp B, Hellstrand P, Nilsson BO, (2009) Polyamine synthesis inhibition induces S phase cell cycle arrest in vascular smooth muscle cells. Amino Acids 36: 273-282.
22. Gupta GK, Dhar K, Del Core MG, Hunter WJ 3rd, Hatzoudis GI, et al. (2011) Suppressor of cytokine signaling-3 and intimal hyperplasia in porcine coronary arteries following coronary intervention. Exp Mol Pathol 91: 346-352.
23. Kim JS, Cross JM, Bamman MM, (2005) Impact of resistance loading on myostatin expression and cell cycle regulation in young and older men and women. Am J Physiol Endocrinol Metab 288: E1110-1119.
24. Granada JF, Ensenat D, Keswani AN, Kaluza GL, Raizner AE, et al. (2005) Single perivascular delivery of mitomycin C stimulates p21 expression and inhibits neointima formation in rat arteries. Arterioscler Thromb Vasc Biol 25: 2343-2348.
25. Filardo EJ, Quinn JA, Bland KI, Frackelton AR Jr, (2000) Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 14: 1649-1660.
26. Filardo EJ, Quinn JA, Frackelton AR Jr, Bland KI, (2002) Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol 16: 70-84.
27. Chan QK, Lam HM, Ng CF, Lee AY, Chan ES, et al. (2010) Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest. Cell Death Differ 17: 1511-1523.
28. Ranganna K, Yousefipour Z, Yatsu FM, Milton SG, Hayes BE, (2003) Gene expression profile of butyrate-inhibited vascular smooth muscle cell proliferation. Mol Cell Biochem 254: 21-36.
29. Tian JQ, Quaroni A, (1999) Involvement of p21(WAF1/Cip1) and p27(Kip1) in intestinal epithelial cell differentiation. Am J Physiol 276: C1245-1258.
30. Yu JJ, Kirkland TN, Hall LK, Wopschall J, Smith RC, et al. (2005) Characterization of a serodiagnostic complement fixation antigen of Coccidioides posadasii expressed in the nonpathogenic Fungus Uncinocarpus reesii. J Clin Microbiol 43: 5462-5469.
31. Zhao Y, Lv M, Lin H, Cui Y, Wei X, et al. (2013) Rho-associated protein kinase isoforms stimulate proliferation of vascular smooth muscle cells through ERK and induction of cyclin D1 and PCNA. Biochem Biophys Res Commun.
32. Yena S, Doddoli C, Doumbia S, D'Journo XB, Aragon A, et al. (2006) [Bronchial fistula postpneumonectomy: predictive factors]. Ann Chir 131: 22-26.
33. Pandey DP, Lappano R, Albanito L, Madeo A, Maggiolini M, et al. (2009) Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF. EMBO J 28: 523-532.
34. Ignatov T, Eggemann H, Semczuk A, Smith B, Bischoff J, et al. (2010) Role of GPR30 in endometrial pathology after tamoxifen for breast cancer. Am J Obstet Gynecol 203: e599-516, 595, e599-516.
35. Filigheddu N, Sampietro S, Chianale F, Porporato PE, Gaggianesi M, et al. (2011) Diacylglycerol kinase alpha mediates 17-beta-estradiol-induced proliferation, motility, and anchorage-independent growth of Hec-1A endometrial cancer cell line through the G protein-coupled estrogen receptor GPR30. Cell Signal 23: 1988-1996.
36. Albanito L, Madeo A, Lappano R, Vivacqua A, Rago V, et al. (2007) G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res 67: 1859-1866.
37. Yun ES, Park SS, Shin HC, Choi YH, Kim WJ, et al. (2011) p38 MAPK activation is required for esculetin-induced inhibition of vascular smooth muscle cells proliferation. Toxicol In Vitro 25: 1335-1342.
38. Mathew OP, Ranganna K, Yatsu FM, (2010) Butyrate, an HDAC inhibitor, stimulates interplay between different posttranslational modifications of histone H3 and differently alters G1-specific cell cycle proteins in vascular smooth muscle cells. Biomed Pharmacother 64: 733-740.
39. Riendeau V, Garenc C, (2009) Effect of 27-hydroxycholesterol on survival and death of human macrophages and vascular smooth muscle cells. Free Radic Res 43: 1019-1028.
40. Chaterji S, Park K, Panitch A, (2010) Scaffold-free in vitro arterial mimetics: the importance of smooth muscle-endothelium contact. Tissue Eng Part A 16: 1901-1912.
41. Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, et al. (1995) p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 267: 1024-1027.
42. Yan GZ, Ziff EB, (1995) NGF regulates the PC12 cell cycle machinery through specific inhibition of the Cdk kinases and induction of cyclin D1. J Neurosci 15: 6200-6212.